# CBL & Associates Properties Inc: financial statements, quarterly

CBL · NYSE · CIK 910612 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbl.md) · [Financials](/companies/cbl/financials.md) · [Filings](/companies/cbl/filings.md) · [Insiders](/companies/cbl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.0](/filings/0000950170-24-125286.md) | [5.3 d](/filings/0001193125-26-087049.md) | [4.6](/filings/0000950170-25-063585.md) | [4.3](/filings/0000950170-25-103884.md) | [4.5](/filings/0001193125-25-272118.md) | [5.2 d](/filings/0001193125-26-087049.md) | [3.6](/filings/0001193125-26-214023.md) | [3.9](/filings/0001193125-26-339651.md) | [4.0](/filings/0001193125-25-272118.md) | [4.8 d](/filings/0001193125-26-087049.md) | [4.3](/filings/0001193125-26-214023.md) | [4.0](/filings/0001193125-26-339651.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [42.9](/filings/0000950170-24-125286.md) | [42.3 d](/filings/0000950170-24-023267.md) | [39.8](/filings/0000950170-24-057509.md) | [39.4](/filings/0000950170-24-094439.md) | [38.8](/filings/0000950170-24-125286.md) | [36.4 d](/filings/0001193125-26-087049.md) | [44.2](/filings/0001193125-26-214023.md) | [44.0](/filings/0001193125-26-339651.md) | [44.8](/filings/0001193125-25-272118.md) | [43.0 d](/filings/0001193125-26-087049.md) | [39.9](/filings/0001193125-26-214023.md) | [42.7](/filings/0001193125-26-339651.md) |
| Income tax | $m | [1.3](/filings/0000950170-24-125286.md) | [(0.5) d](/filings/0001193125-26-087049.md) | [(0.2)](/filings/0000950170-25-063585.md) | [0.7](/filings/0000950170-25-103884.md) | [0.4](/filings/0001193125-25-272118.md) | [0.2 d](/filings/0001193125-26-087049.md) | [(0.5)](/filings/0001193125-26-214023.md) | [0.4](/filings/0001193125-26-339651.md) | [0.0](/filings/0001193125-25-272118.md) | [0.5 d](/filings/0001193125-26-087049.md) | [(1.2)](/filings/0001193125-26-214023.md) | [0.6](/filings/0001193125-26-339651.md) |
| Net income | $m | [13.3](/filings/0000950170-24-125286.md) | [11.8 d](/filings/0001193125-26-087049.md) | [0.1](/filings/0000950170-25-063585.md) | [4.7](/filings/0000950170-25-103884.md) | [16.2](/filings/0001193125-25-272118.md) | [38.0 d](/filings/0001193125-26-087049.md) | [8.8](/filings/0001193125-26-214023.md) | [2.8](/filings/0001193125-26-339651.md) | [75.4](/filings/0001193125-25-272118.md) | [49.0 d](/filings/0001193125-26-087049.md) | [46.5](/filings/0001193125-26-214023.md) | [46.4](/filings/0001193125-26-339651.md) |
| Diluted EPS | $ per share | [0.41](/filings/0000950170-24-125286.md) | not reported | [(0.01)](/filings/0000950170-25-063585.md) | [0.14](/filings/0000950170-25-103884.md) | [0.52](/filings/0001193125-25-272118.md) | not reported | [0.27](/filings/0001193125-26-214023.md) | [0.08](/filings/0001193125-26-339651.md) | [2.38](/filings/0001193125-25-272118.md) | not reported | [1.48](/filings/0001193125-26-214023.md) | [1.47](/filings/0001193125-26-339651.md) |
| Basic EPS | $ per share | [0.41](/filings/0000950170-24-125286.md) | not reported | [(0.01)](/filings/0000950170-25-063585.md) | [0.14](/filings/0000950170-25-103884.md) | [0.52](/filings/0001193125-25-272118.md) | not reported | [0.27](/filings/0001193125-26-214023.md) | [0.08](/filings/0001193125-26-339651.md) | [2.44](/filings/0001193125-25-272118.md) | not reported | [1.50](/filings/0001193125-26-214023.md) | [1.50](/filings/0001193125-26-339651.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.5](/filings/0000950170-24-125286.md) | [34.2](/filings/0001193125-26-087049.md) | [57.7](/filings/0000950170-25-103884.md) | [57.7](/filings/0000950170-24-094439.md) | [65.1](/filings/0001193125-25-272118.md) | [40.8](/filings/0001193125-26-087049.md) | [29.8](/filings/0001193125-26-214023.md) | [100](/filings/0001193125-26-339651.md) | [52.6](/filings/0001193125-25-272118.md) | [42.3](/filings/0001193125-26-339651.md) | [123](/filings/0001193125-26-214023.md) | [101](/filings/0001193125-26-339651.md) |
| Total assets | $m | [2,436](/filings/0000950170-23-062150.md) | [2,406](/filings/0000950170-25-030677.md) | [2,344](/filings/0000950170-24-057509.md) | [2,322](/filings/0000950170-24-094439.md) | [2,248](/filings/0000950170-24-125286.md) | [2,747](/filings/0001193125-26-087049.md) | [2,625](/filings/0000950170-25-063585.md) | [2,603](/filings/0000950170-25-103884.md) | [2,730](/filings/0001193125-25-272118.md) | [2,729](/filings/0001193125-26-339651.md) | [2,645](/filings/0001193125-26-214023.md) | [2,637](/filings/0001193125-26-339651.md) |
| Total liabilities | $m | [2,107](/filings/0000950170-23-062150.md) | [2,075](/filings/0000950170-25-030677.md) | [2,029](/filings/0000950170-24-057509.md) | [2,023](/filings/0000950170-24-094439.md) | [1,950](/filings/0000950170-24-125286.md) | [2,434](/filings/0001193125-26-087049.md) | [2,341](/filings/0000950170-25-063585.md) | [2,325](/filings/0000950170-25-103884.md) | [2,389](/filings/0001193125-25-272118.md) | [2,364](/filings/0001193125-26-339651.md) | [2,258](/filings/0001193125-26-214023.md) | [2,215](/filings/0001193125-26-339651.md) |
| Long-term debt | $m | [1,900](/filings/0000950170-23-062150.md) | [1,889](/filings/0000950170-25-030677.md) | [1,860](/filings/0000950170-24-057509.md) | [1,853](/filings/0000950170-24-094439.md) | [1,775](/filings/0000950170-24-125286.md) | [2,213](/filings/0001193125-26-087049.md) | [2,151](/filings/0000950170-25-063585.md) | [2,140](/filings/0000950170-25-103884.md) | [2,181](/filings/0001193125-25-272118.md) | [2,171](/filings/0001193125-26-339651.md) | [2,079](/filings/0001193125-26-214023.md) | [2,034](/filings/0001193125-26-339651.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.2](/filings/0001193125-26-087049.md) | [2,103](/filings/0001193125-26-214023.md) | [1,962](/filings/0001193125-26-339651.md) |
| Shareholders' equity | $m | [338](/filings/0000950170-23-062150.md) | [339](/filings/0000950170-25-030677.md) | [324](/filings/0000950170-24-057509.md) | [309](/filings/0000950170-24-094439.md) | [308](/filings/0000950170-24-125286.md) | [324](/filings/0001193125-26-087049.md) | [295](/filings/0000950170-25-063585.md) | [289](/filings/0000950170-25-103884.md) | [351](/filings/0001193125-25-272118.md) | [375](/filings/0001193125-26-339651.md) | [398](/filings/0001193125-26-214023.md) | [427](/filings/0001193125-26-339651.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.9 d](/filings/0000950170-24-125286.md) | [49.4 d](/filings/0001193125-26-087049.md) | [30.7](/filings/0000950170-25-063585.md) | [64.2 d](/filings/0000950170-25-103884.md) | [61.1 d](/filings/0001193125-25-272118.md) | [46.2 d](/filings/0001193125-26-087049.md) | [31.7](/filings/0001193125-26-214023.md) | [68.3 d](/filings/0001193125-26-339651.md) | [69.6 d](/filings/0001193125-25-272118.md) | [80.2 d](/filings/0001193125-26-087049.md) | [52.9](/filings/0001193125-26-214023.md) | [80.3 d](/filings/0001193125-26-339651.md) |
| Dividends paid | $m | [12.0 d](/filings/0000950170-24-125286.md) | [12.0 d](/filings/0001193125-26-087049.md) | [12.9](/filings/0000950170-25-063585.md) | [12.7 d](/filings/0000950170-25-103884.md) | [12.5 d](/filings/0001193125-25-272118.md) | [12.3 d](/filings/0001193125-26-087049.md) | [37.1](/filings/0001193125-26-214023.md) | [12.4 d](/filings/0001193125-26-339651.md) | [13.9 d](/filings/0001193125-25-272118.md) | [13.7 d](/filings/0001193125-26-087049.md) | [13.9](/filings/0001193125-26-214023.md) | [24.8 d](/filings/0001193125-26-339651.md) |
| Share repurchases | $m | not reported | [0.3 d](/filings/0001193125-26-087049.md) | [5.0](/filings/0000950170-25-063585.md) | [11.0 d](/filings/0000950170-25-103884.md) | [7.9 d](/filings/0001193125-25-272118.md) | [12.5 d](/filings/0001193125-26-087049.md) | [0.0](/filings/0001193125-26-214023.md) | [0.0 d](/filings/0001193125-26-339651.md) | [4.2 d](/filings/0001193125-25-272118.md) | [13.9 d](/filings/0001193125-26-087049.md) | [1.3](/filings/0001193125-26-214023.md) | [0.0 d](/filings/0001193125-26-339651.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0000950170-23-062150.md) | [0.0](/filings/0000950170-24-057509.md) | [0.0](/filings/0000950170-24-094439.md) | [0.0](/filings/0000950170-24-125286.md) | [31.5](/filings/0000950170-25-063585.md) | [31.2](/filings/0000950170-25-103884.md) | [30.8](/filings/0001193125-25-272118.md) | [30.7](/filings/0001193125-26-214023.md) | [30.7](/filings/0001193125-26-339651.md) | [31.3](/filings/0001193125-25-272118.md) | [30.7](/filings/0001193125-26-214023.md) | [30.9](/filings/0001193125-26-339651.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,942,757 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339651.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.